Table 2.

The effects of dienogest and GnRH agonist on different aspects of endometriosis before and after treatment

Variables	Dienogest			GnRH agonist
	Before	After	P-value	Before	After	P-value
Dysmenorrhea*	7.981 $\pm$ 2.356	3.654 $\pm$ 2.457	$<$ 0.0001	8.115 $\pm$ 1.916	3.442 $\pm$ 2.461	$<$ 0.0001
Dyspareunia**	5.500 (3.250–8.000)	2.000 (0.000–4.000)	$<$ 0.0001	5.000 (3.000–7.000)	0.000 (0.000–4.000)	$<$ 0.0001
Dyschezia**	3.000 (0.000–7.000)	2.000 (0.000–4.000)	$<$ 0.0001	3.000 (0.000–8.000)	2.000 (0.000–6.000)	$<$ 0.0001
Irregular vaginal bleeding***	22 (42.31)	6 (11.54)	0.0007	20 (38.46)	4 (7.69)	0.0003
*Data presented as Mean $\pm$ SD, Wilcoxon matched-pairs signed rank test. **Data presented as Median (IQR), Wilcoxon matched-pairs signed rank test. ***Data presented as n (%), Fisher's exact test. GnRH: Gonadotropin-releasing hormone agonist